Zai Lab Ltd
(NAS:ZLAB)
$
30.92
0.03 (0.1%)
Market Cap: 3.15 Bil
Enterprise Value: 2.53 Bil
PE Ratio: 0
PB Ratio: 4.31
GF Score: 81/100 Zai Lab Ltd at Citi BioPharma Conference (Virtual) Transcript
Sep 10, 2021 / 03:35PM GMT
Release Date Price:
$137.34
(+0.26%)
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
Okay. Great. Welcome, everyone, to the Fireside Chat with Zai Lab. I'm Yigal Nochomovitz, one of the biotech analysts at Citi. It's my pleasure to have with me Tao Fu, who is the Chief Strategy Officer at Zai Lab. Welcome, Tao.
Tao Fu
Zai Lab Limited - Chief Strategy Officer
Thank you, Yigal. Thanks for having us.
Questions & Answers
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director
Of course. So I think to start out, maybe a good place to start would be to summarize Zai Lab's broad strategy for those listening that are less familiar with the story. What is the near-term mission of the company? And also, what is the long-term mission of Zai Lab?
Tao Fu
Zai Lab Limited - Chief Strategy Officer
Yes. Thanks for that question. So Zai Lab is still a relatively young company, just founded 7 years ago by our CEO, Samantha Du. We started from really being a partner of choice for U.S
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot